DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Cambrex Corp (NYSE: CBM)

22.43 -0.44 (-1.92%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CBM $22.43 -1.92%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $22.61
Previous Close $22.87
Daily Range $22.34 - $22.75
52-Week Range $15.76 - $24.45
Market Cap $695.2M
P/E Ratio 18.15
Dividend (Yield) $0.00 (0.0%)
Volume 229,172
Average Daily Volume 200,846
Current FY EPS $1.13

Sector

Healthcare

Industry

Drugs

Cambrex Corp (CBM) Description

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics. Website: http://www.cambrex.com/

News & Commentary Rss Feed

Why Cambrex Corporation Shares Dipped

Cambrex shares dive following the company's first-quarter earnings results. Find out whether this dip is a buying opportunity or a reason to avoid this stock.

Can the Rally in Cambrex (CBM) Shares Continue? - Tale of the Tape

Cambrex's (CBM) CEO Steve Klosk on Q3 2014 Results -- Earnings Call Transcript

Cambrex (CBM) Q3 2014 Results - Earnings Call Webcast

Commit To Buy Cambrex Corp At $15, Earn 11.3% Annualized Using Options

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Halozyme's PEGPH20 Receives FDA Orphan Drug Designation - Analyst Blog

Pluristem Therapeutics, Inc. (PSTI) in Focus: Stock Up 7.4% - Tale of the Tape

Alexion Pharmaceuticals (ALXN) in Focus: Stock Rises 6.0% - Tale of the Tape

Weakness Seen in Vital Therapies (VTL): Stock Falls 6.3% - Tale of the Tape

Weakness Seen in Vital Therapies (VTL): Stock Falls 6.3% - Tale of the Tape

CorMedix Files IND Application for Neutrolin in the US - Analyst Blog

Ambit Biosciences (AMBI) Soars: Stock Adds 87.1% - Tale of the Tape

See More CBM News...

CBM's Top Competitors

CBM $22.43 (-1.92%)
Current stock: CBM
TMO $125.21 (-2.15%)
Current stock: TMO
ILMN $195.19 (-2.41%)
Current stock: ILMN
WAT $119.05 (-1.30%)
Current stock: WAT